Suppr超能文献

针刺联合中药与单纯中药相比提高子宫肌瘤临床疗效的系统评价与Meta分析

Acupuncture combined with Chinese herbs versus Chinese herbs alone to improve the clinical efficacy of uterine fibroids: a systematic review and meta-analysis.

作者信息

Chen Tianyu, Chen Xin, He Wei, Ma Xiaojing, Zuo Zheng

机构信息

College of Acupuncture and Tuina, Yunnan University of Traditional Chinese Medicine, Yunnan, China.

出版信息

Front Oncol. 2024 Nov 21;14:1456809. doi: 10.3389/fonc.2024.1456809. eCollection 2024.

Abstract

OBJECTIVE

The objective of this study was to evaluate the clinical efficacy of acupuncture combined with Chinese herbs versus Chinese herbs alone in treating uterine fibroids.

METHODS

A literature search of eight databases identified nine randomized controlled trials (RCTs) evaluating the clinical efficacy of acupuncture combined with Chinese herbs compared to Chinese herbs alone for treating uterine fibroids. Subsequently, data extraction and analysis were conducted to assess the methodological quality and risk of bias in the studies, followed by an analysis of the data from the randomized controlled trials.

RESULTS

Nine randomized controlled trials involving 640 women were included. The results indicated that acupuncture combined with Chinese herbs significantly increased the overall clinical efficacy rate [Z=5.00, P=0.74, relative risk(RR)1.20, 95%CI 1.12 to 1.30, P<0.00001, I²=0%] and reduced the size of uterine fibroids [Z=2.95, P=0.003, SMD=-0.82, 95%CI -1.36 to -0.27, P<0.00001, I²=90%].

CONCLUSIONS

Studies have shown that acupuncture combined with Chinese herbs reduces uterine size, lowers hormone levels, and improves quality of life. According to the findings of this study, acupuncture combined with Chinese herbs has a more positive effect on the treatment of uterine fibroids than Chinese herbs alone. However, due to the limited number and quality of the included studies, these conclusions need to be validated by further high-quality research.

SYSTEMATIC REVIEW REGISTRATION

https://www.crd.york.ac.uk/PROSPERO/#myprospero, identifier CRD42024507248.

摘要

目的

本研究旨在评估针刺联合中药与单纯中药治疗子宫肌瘤的临床疗效。

方法

通过检索八个数据库,确定了九项随机对照试验(RCT),这些试验评估了针刺联合中药与单纯中药治疗子宫肌瘤的临床疗效。随后,进行数据提取和分析,以评估研究的方法学质量和偏倚风险,接着对随机对照试验的数据进行分析。

结果

纳入了九项涉及640名女性的随机对照试验。结果表明,针刺联合中药显著提高了总体临床有效率[Z = 5.00,P = 0.74,相对危险度(RR)1.20,95%置信区间1.12至1.30,P < 0.00001,I² = 0%],并减小了子宫肌瘤的大小[Z = 2.95,P = 0.003,标准化均数差(SMD)=-0.82,95%置信区间-1.36至-0.27,P < 0.00001,I² = 90%]。

结论

研究表明,针刺联合中药可减小子宫大小、降低激素水平并改善生活质量。根据本研究结果,针刺联合中药治疗子宫肌瘤比单纯中药具有更积极的效果。然而,由于纳入研究的数量和质量有限,这些结论需要通过进一步的高质量研究来验证。

系统评价注册

https://www.crd.york.ac.uk/PROSPERO/#myprospero,标识符CRD42024507248。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d84b/11617359/c31624d508a3/fonc-14-1456809-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验